Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Controlled Study of Olanzapine in Children With Autism

This study has been completed.
National Institute of Mental Health (NIMH)
Information provided by:
FDA Office of Orphan Products Development Identifier:
First received: April 1, 2003
Last updated: March 24, 2015
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given